Denmark. Demant A/S

Date of agreement:04 Jul 2022
Customer:Demant A/S
Amount in DKK:DKK 750 million
Amount in EUR:EUR 100.8 million
Maturity:7 years
NACE sector / loan type:Research and development


NIB provides a loan to co-finance Demant’s research and development.

Demant has a very significant and comprehensive R&D programme, and a very large portion of this is carried out in close cooperation with several universities, research centers and companies in Denmark.

Since 2015 NIB has been an important financier of Demant’s Research and Development Programme and concluded three loans with the company for that purpose, in total amounting to EUR 194 million. In addition, NIB concluded a Covid response loan with Demant in 2020, amounting to EUR 60 million.

Demant A/S is an internationally leading company in the field of modern hearing solutions. The company is majority-owned by the William Demant Foundation. The group offers solutions and services to help people connect and communicate with the world around them, and focuses on four business activities: Hearing Aids, Hearing Care, Diagnostics and Communication.

Fulfilment of NIB's mandate

The R&D that is carried out by the company and subsequent commercialization efforts are likely going to have a positive effect on to the life quality of people suffering from hearing disabilities, enabling them to fully participate in social and work life from which they otherwise would have been excluded.

Sustainability summary

NIB has not identified any concerns nor significant environmental issues connected to the R&D programme.

Press release

NIB helps finance Danish hearing healthcare technology

Press release

NIB hjælper med at finansiere dansk høreplejeteknologi